![Anita P. Wilén-Koort](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anita P. Wilén-Koort
Plus aucun poste en cours
Profil
Ms Anita Wilén-Koort, Partner and Investment Manager, joined GZ Group in May 2000 and is responsible for identifying and evaluating investment opportunities, managing transactions, investments and GZ Group’s existing portfolio companies.
She has a focus on drug discovery, development, biotech tool suppliers and health care information technology.
Ms Wilén-Koort currently serves as board member in Index Pharmaceuticals AB and deputy board member in Neoventa Medical AB.
Before joining GZ Group, Ms Wilén-Koort held various managerial positions at Pharmacia & Upjohn AB. During her 15 year long career at Pharmacia she has been working in areas such as Business Control, Corporate Strategic Analysis and Planning and Business Development.
Most recently Ms Wilén-Koort worked as Global Business Intelligence and Marketing Research Manager supporting two different strategic product areas in the company – Urology and Ophthalmology involving global launches of Detrusitol/Detrol and Xalatan, both best selling products in their respective class.
Xalatan has sales exceeding 1 billion USD and Detrusitol/Detrol is expected to reach 1 billion USD in sales in near future.
Ms Wilén-Koort has a B Sc in Business Administration from Uppsala University and an Executive MBA from Stockholm School of Economics.
Anciens postes connus de Anita P. Wilén-Koort
| Sociétés | Poste | Fin |
|---|---|---|
Life Equity Group Holding AB
 Life Equity Group Holding AB Investment ManagersFinance Life Equity Group is an active manager which provides financing for early, later and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in health services and health technology sector, and industries such as biotechnology, pharmaceuticals, and medical specialties. It invests in young companies located in Northern Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Private Equity Investor | 01/11/2010 |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Directeur/Membre du Conseil | - |
| FLERIE INVEST AB | Directeur/Membre du Conseil | - |
Formation de Anita P. Wilén-Koort
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Life Equity Group Holding AB
Life Equity Group Holding AB Investment ManagersFinance Life Equity Group is an active manager which provides financing for early, later and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in health services and health technology sector, and industries such as biotechnology, pharmaceuticals, and medical specialties. It invests in young companies located in Northern Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
